Menu
Back to User profile » Professor Thomas Wilke
Papers published by Professor Thomas Wilke:
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany
Beeh KM, Rothnie KJ, Claussen J, Hardtstock F, Knapp RK, Wilke T, Czira A, Compton C, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:945-956
Published Date: 17 April 2024
Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
Buhl R, Wilke T, Picker N, Schmidt O, Hechtner M, Kondla A, Maywald U, Vogelmeier CF
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2355-2367
Published Date: 22 September 2022
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
Wilke T, Picker N, Müller S, Stürmlinger A, Deiters B, Dittmar A, Aberle J, Gabler M
ClinicoEconomics and Outcomes Research 2022, 14:319-332
Published Date: 2 May 2022
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study
Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Mueller S, Böhm M
Integrated Blood Pressure Control 2022, 15:11-21
Published Date: 27 February 2022
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1397-1398
Published Date: 14 August 2019
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1225-1237
Published Date: 24 July 2019
Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?
Wilke T, Mueller S, Bauer S, Pitura S, Probst L, Ratsch BA, Salwender H
Patient Preference and Adherence 2018, 12:2387-2396
Published Date: 9 November 2018
Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
Müller S, Wilke T, Fuchs A, Maywald U, Flacke JP, Heinisch H, Krüger K
Patient Preference and Adherence 2017, 11:1253-1264
Published Date: 20 July 2017